| Popis: |
Effectiveness and tolerance of low to very low dose thalidomide in low-risk myelodysplastic syndromes J. Tamburini a,∗, C. Elie b, S. Park a, O. Beyne-Rauzy c, M. Gardembas d, C. Berthou e, B. Mahe f, L. Sanhes g, A. Stamatoullas h, N. Vey i, A. Aouba j, B. Slama k, B. Quesnel l, A. Vekhoff n, J.J. Sotto m, D. Vassilief a, C. Al-Nawakil a, P. Fenaux o, F. Dreyfus a, D. Bouscary a, for the “Groupe Francophone des Myelodysplasies, GFM” a Department of haematology Hopital Cochin, France b Department of biostatistiques universite Paris 5, France c Department of Hematology Odile; Hopital Purpan, Toulouse, France d Department of Hematology Martine; Centre Hospitalier d’Angers, France e Department of Hematology Christian; Hopital de Brest, France f Department of Hematology Centre hospitalier de Nantes, France g Department of Hematology Centre Hospitalier de Perpignan, France h Department of Hematology Aspasia; Centre Hospitalier de Rouen, France i Department of HematologyInstitut Paoli Calmette, Marseille, France j Hopital Cochin, Paris, internal medicine, France k Department of Hematology Centre Hospitalier d’Avignon, France l Department of Hematology Centre Hospitalier de Lille, France m Department of Hematology Centre Hospitalier de Grenoble, France n Department of Hematology Hopital Hotel Dieu, Paris, Hematology, France o Department of Hematology Hopital Avicenne, Bobigny, France |
Full Text from ScienceDirect